Stoke Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stoke Therapeutics, Inc.
CIK #0001623526
EDGAR Form CIK 2011 - 2025
10-K [0001623526]
10-Q [0001623526]
3 [0001623526]
4 [0001623526]
8-K [0001623526]
D [0001623526]
SC 13D [0001623526]
SC 13G [0001623526]
Form 13D/13G Filer Form 13D/13G Subject Filed
FMR LLC Stoke Therapeutics Inc [2025-06-06]
BlackRock Portfolio Management LLC Stoke Therapeutics Inc [2025-04-15]
Baker Bros Advisors LP Stoke Therapeutics Inc [2024-11-14]
BlackRock Inc Stoke Therapeutics Inc [2024-07-08]
Cowen Financial Products LLC Stoke Therapeutics Inc [2024-02-26]
Lynx1 Capital Management LP Stoke Therapeutics Inc [2023-11-06]
Morgan Stanley Stoke Therapeutics Inc [2023-02-10]
Vanguard Group Inc Stoke Therapeutics Inc [2022-02-10]
Cowen Financial Products LLC Stoke Therapeutics Inc [2022-01-24]
Skorpios Trust Stoke Therapeutics Inc [2021-06-30]
View All
Form 3/4/5 Subject 2011 - 2025
Stoke Therapeutics, Inc.
Kaye Edward M. MD
Allan Jonathan
Ticho Barry
Levin Arthur A
Hoitt Jason
Montrago Trustees Ltd
Blue Horizon Enterprise Ltd
Skorpios Trust
Ezbon International Ltd
Smith Julie
Menzel Garry E
Krainer Adrian R.
Harrison Seth Loring
Burstein Jennifer
Smith Ian F
Tzianabos Arthur
Leggett Thomas
Nash Huw M.
Tulipano Stephen J
ATP Life Science Ventures, L.P.
ATP III GP, Ltd.
Liau Gene
Walker Robin A.
Wong Roderick
RTW Investments LP
Hall Samuel W.
Redmile Group, LLC
Green Jeremy
Terms | Privacy | Guide
tony@aum13f.com